BiotechTube

OLZ/SAM

Phase 3Recruiting
0 views this week 0 watching⚡ Active🧠Featured in Neuroscience Pipeline Watch
Interest: 44/100
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bipolar I Disorder

Conditions

Bipolar I Disorder, Schizophrenia

Trial Timeline

Oct 22, 2021 → Sep 1, 2027

NCT ID
NCT04987229

About OLZ/SAM

OLZ/SAM is a phase 3 stage product being developed by Alkermes for Bipolar I Disorder. The current trial status is recruiting. This product is registered under clinical trial identifier NCT04987229. Target conditions include Bipolar I Disorder, Schizophrenia.

What happened to similar drugs?

20 of 20 similar drugs in Bipolar I Disorder were approved

Approved (20) Terminated (3) Active (0)
✅Olanzapine + PlaceboEli LillyApproved
✅OlanzapineEli LillyApproved
✅OlanzapineEli LillyApproved
✅olanzapine + divalproex sodium + placeboEli LillyApproved
✅olanzapine + risperidoneEli LillyApproved
✅Topiramate + PlaceboEli LillyApproved
✅Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved

Hype Score Breakdown

Clinical
17
Activity
15
Company
12
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT04987229Phase 3Recruiting
NCT04987658Phase 1Completed

Competing Products

20 competing products in Bipolar I Disorder

See all competitors
ProductCompanyStageHype Score
OlanzapineEli LillyPhase 3
32
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyApproved
43
FK949EAstellas PharmaPhase 3
40
FK949EAstellas PharmaPhase 3
40
FK949E + PlaceboAstellas PharmaPhase 2/3
38
Escitalopram + Bupropion XLLupin LimitedPhase 3
32
OlanzapineEli LillyApproved
43
Olanzapine Hydrochloride + Lithium CarbonateEli LillyPhase 3
40
olanzapine + lithium + valproate + carbamazepineEli LillyPhase 3
40
OlanzapineEli LillyApproved
43
OlanzapineEli LillyPhase 3
40
LY2979165 + PlaceboEli LillyPhase 1
29
olanzapine + divalproex sodium + placeboEli LillyApproved
43
olanzapine + risperidoneEli LillyApproved
43
LY2979165 + placeboEli LillyPhase 1
29
Topiramate + PlaceboEli LillyApproved
43
olanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyPhase 3
40
Brenipatide + PlaceboEli LillyPhase 2
42